Table 2.
Cmpd No. |
R2 | IC50 SRE.L (μM) |
% inh SRE.L (100 μM) |
% inh WST-1 (100 μM) |
---|---|---|---|---|
2 | 4-Cl | 9.8 | 78 | 14 |
12a | PhO | 1.5 | 59 | 1 |
12b | PhCH2 | 1.6 | 59 | 0 |
12c | 2-Pyr-CH2CH2O | 2.3 | 82 | 5 |
12d | pyrrolidin-1-yl-SO2 | 5.6 | 70 | 0 |
12e | 2-Me-thiazol-4-yl | 6.1 | 73 | 1 |
12f | Et | 8.1 | 66 | 0 |
12g | CH2=CH | 11 | 53 | 1 |
12h | oxazol-5-yl | 12 | 87 | 9 |
12i | MeS | 12 | 60 | 0 |
12j | MeO2C | 26 | 63 | 0 |
12k | MeO | 30 | 51 | 0 |
12l | −CN | 32 | 77 | 0 |
12m | morpholin-1-yl-CH2 | 32 | 73 | 0 |
12n | −NO2 | 66 | 65 | 9 |
12o | MeCO | 76 | 73 | 0 |
12p | pyrrolidin-1-yl-CH2 | ND | 94 | 51 |
12q | 2-CO2Me-furan-4-yl | ND | 39 | 0 |
12r | CH2=CHCH2O | ND | 38 | 0 |
12s | PhCO | ND | 38 | 0 |
12t | 4-methyl-1,2,4-triazol-3-yl | ND | 36 | 0 |
12u | 2-oxopyrrolidin-1-yl | ND | 35 | 0 |
12v | 3-Cl-4-CF3-pyridin-2-yl-O | ND | 25 | 0 |
12w | tBuO2C | ND | 24 | 0 |
Assays and abbreviations defined in Table 1.